Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings

PURPOSE: Conversion chemotherapy is often used for borderline or unresectable (B/U) liver metastases from colorectal cancer (CRC) with the aim of achieving resectability. Although intensive and costly regimens are often used, the best regimen in this scenario remains unclear. We aimed to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonadio, Renata Colombo, Amor Divino, Paulo Henrique, Obando, Jorge Santiago Madero, Lima, Karolina Cayres Alvino, Recchimuzzi, Débora Zachello, Kruger, Jaime Arthur Pirola, Saragiotto, Daniel Fernandes, Capareli, Fernanda C., Hoff, Paulo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733184/
https://www.ncbi.nlm.nih.gov/pubmed/31479339
http://dx.doi.org/10.1200/JGO.19.00180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733184/
https://www.ncbi.nlm.nih.gov/pubmed/31479339
http://dx.doi.org/10.1200/JGO.19.00180

Ejemplares similares